Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Mar;3(2):156–161. doi: 10.1128/cdli.3.2.156-161.1996

Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants.

W E Katzin 1, L J Feng 1, M Abbuhl 1, M A Klein 1
PMCID: PMC170266  PMID: 8991629

Abstract

The tissue response to silicone gel breast implants typically includes an inflammatory infiltrate that consists of macrophages, foreign body-type giant cells, and a variable number of lymphocytes and plasma cells. The phenotype of the lymphocytic component was investigated with three-color flow cytometry. Lymphocytes were obtained by collecting fluid from the space between the implant and the fibrous capsule or by washing cells from the fibrous capsule at the time of implant removal with total capsulectomy. Eighty-nine percent of the implant-associated lymphocytes were T cells. Twenty-five percent of the CD3+ T cells coexpressed HLA-DR compared with only 7.9% of matched peripheral blood lymphocytes. Sixty-eight percent of the implant-associated T cells coexpressed CD4 and CD29, while only 3% of the T cells coexpressed CD4 and CD45RO. The expression of HLA-DR and the predominance of CD29+ CD4+ T cells indicate that there is immune activation with the potential for stimulating antigen-specific antibody production. The role of silicone gel breast implants in immune activation and its clinical significance require further investigation.

Full Text

The Full Text of this article is available as a PDF (198.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker J. L., Jr, LeVier R. R., Spielvogel D. E. Positive identification of silicone in human mammary capsular tissue. Plast Reconstr Surg. 1982 Jan;69(1):56–60. [PubMed] [Google Scholar]
  2. Baldwin C. M., Jr, Kaplan E. N. Silicone-induced human adjuvant disease? Ann Plast Surg. 1983 Apr;10(4):270–273. doi: 10.1097/00000637-198304000-00002. [DOI] [PubMed] [Google Scholar]
  3. Brandt B., Breiting V., Christensen L., Nielsen M., Thomsen J. L. Five years experience of breast augmentation using silicone gel prostheses with emphasis on capsule shrinkage. Scand J Plast Reconstr Surg. 1984;18(3):311–316. doi: 10.3109/02844318409052856. [DOI] [PubMed] [Google Scholar]
  4. Brantley S. K., Davidson S. F., St Arnold P. A., Johnson M. B., Talbot P. J., Grogan J. B., Cuchens M. A., Hsu H. S., Das S. K. Assessment of the lymphocyte response to silicone. Plast Reconstr Surg. 1990 Dec;86(6):1131–1137. doi: 10.1097/00006534-199012000-00015. [DOI] [PubMed] [Google Scholar]
  5. Bridges A. J., Conley C., Wang G., Burns D. E., Vasey F. B. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 1993 Jun 15;118(12):929–936. doi: 10.7326/0003-4819-118-12-199306150-00003. [DOI] [PubMed] [Google Scholar]
  6. Brozena S. J., Fenske N. A., Cruse C. W., Espinoza C. G., Vasey F. B., Germain B. F., Espinoza L. R. Human adjuvant disease following augmentation mammoplasty. Arch Dermatol. 1988 Sep;124(9):1383–1386. [PubMed] [Google Scholar]
  7. Cush J. J., Lipsky P. E. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum. 1988 Oct;31(10):1230–1238. doi: 10.1002/art.1780311003. [DOI] [PubMed] [Google Scholar]
  8. Endo L. P., Edwards N. L., Longley S., Corman L. C., Panush R. S. Silicone and rheumatic diseases. Semin Arthritis Rheum. 1987 Nov;17(2):112–118. doi: 10.1016/0049-0172(87)90033-3. [DOI] [PubMed] [Google Scholar]
  9. Fisher J. C. The silicone controversy--when will science prevail? N Engl J Med. 1992 Jun 18;326(25):1696–1698. doi: 10.1056/NEJM199206183262511. [DOI] [PubMed] [Google Scholar]
  10. Gabriel S. E., O'Fallon W. M., Kurland L. T., Beard C. M., Woods J. E., Melton L. J., 3rd Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994 Jun 16;330(24):1697–1702. doi: 10.1056/NEJM199406163302401. [DOI] [PubMed] [Google Scholar]
  11. Gayou R. M. A histological comparison of contracted and non-contracted capsules around silicone breast implants. Plast Reconstr Surg. 1979 May;63(5):700–707. doi: 10.1097/00006534-197905000-00015. [DOI] [PubMed] [Google Scholar]
  12. Goldblum R. M., Pelley R. P., O'Donell A. A., Pyron D., Heggers J. P. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet. 1992 Aug 29;340(8818):510–513. doi: 10.1016/0140-6736(92)91710-p. [DOI] [PubMed] [Google Scholar]
  13. Hardt N. S., Yu L. T., La Torre G., Steinbach B. Fourier transform infrared microspectroscopy used to identify foreign materials related to breast implants. Mod Pathol. 1994 Aug;7(6):669–676. [PubMed] [Google Scholar]
  14. Hester T. R., Jr, Nahai F., Bostwick J., Cukic J. A 5-year experience with polyurethane-covered mammary prostheses for treatment of capsular contracture, primary augmentation mammoplasty, and breast reconstruction. Clin Plast Surg. 1988 Oct;15(4):569–585. [PubMed] [Google Scholar]
  15. Jabaley M. E., Das S. K. Late breast pain following reconstruction with polyurethane-covered implants. Plast Reconstr Surg. 1986 Sep;78(3):390–395. doi: 10.1097/00006534-198609000-00020. [DOI] [PubMed] [Google Scholar]
  16. Kossovsky N., Freiman C. J. Silicone breast implant pathology. Clinical data and immunologic consequences. Arch Pathol Lab Med. 1994 Jul;118(7):686–693. [PubMed] [Google Scholar]
  17. Kossovsky N., Heggers J. P., Robson M. C. Experimental demonstration of the immunogenicity of silicone-protein complexes. J Biomed Mater Res. 1987 Sep;21(9):1125–1133. doi: 10.1002/jbm.820210906. [DOI] [PubMed] [Google Scholar]
  18. Kumagai Y., Abe C., Shiokawa Y. Scleroderma after cosmetic surgery: four cases of human adjuvant disease. Arthritis Rheum. 1979 May;22(5):532–537. doi: 10.1002/art.1780220514. [DOI] [PubMed] [Google Scholar]
  19. Marik P. E., Kark A. L., Zambakides A. Scleroderma after silicone augmentation mammoplasty. A report of 2 cases. S Afr Med J. 1990 Feb 17;77(4):212–213. [PubMed] [Google Scholar]
  20. Morimoto C., Letvin N. L., Boyd A. W., Hagan M., Brown H. M., Kornacki M. M., Schlossman S. F. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985 Jun;134(6):3762–3769. [PubMed] [Google Scholar]
  21. Morimoto C., Letvin N. L., Distaso J. A., Brown H. M., Schlossman S. F. The cellular basis for the induction of antigen-specific T8 suppressor cells. Eur J Immunol. 1986 Feb;16(2):198–204. doi: 10.1002/eji.1830160216. [DOI] [PubMed] [Google Scholar]
  22. Morimoto C., Romain P. L., Fox D. A., Anderson P., DiMaggio M., Levine H., Schlossman S. F. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases. Am J Med. 1988 May;84(5):817–825. doi: 10.1016/0002-9343(88)90058-7. [DOI] [PubMed] [Google Scholar]
  23. Naim J. O., Lanzafame R. J., van Oss C. J. The adjuvant effect of silicone-gel on antibody formation in rats. Immunol Invest. 1993 Mar;22(2):151–161. doi: 10.3109/08820139309063397. [DOI] [PubMed] [Google Scholar]
  24. Ojo-Amaize E. A., Conte V., Lin H. C., Brucker R. F., Agopian M. S., Peter J. B. Silicone-specific blood lymphocyte response in women with silicone breast implants. Clin Diagn Lab Immunol. 1994 Nov;1(6):689–695. doi: 10.1128/cdli.1.6.689-695.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Picha G. J., Goldstein J. A. Analysis of the soft-tissue response to components used in the manufacture of breast implants: rat animal model. Plast Reconstr Surg. 1991 Mar;87(3):490–500. doi: 10.1097/00006534-199103000-00017. [DOI] [PubMed] [Google Scholar]
  26. Press R. I., Peebles C. L., Kumagai Y., Ochs R. L., Tan E. M. Antinuclear autoantibodies in women with silicone breast implants. Lancet. 1992 Nov 28;340(8831):1304–1307. doi: 10.1016/0140-6736(92)92491-w. [DOI] [PubMed] [Google Scholar]
  27. Raso D. S. Breast prostheses, the immune response, and B- and T-lymphocytes. Plast Reconstr Surg. 1994 Mar;93(3):649–650. [PubMed] [Google Scholar]
  28. Raso D. S., Crymes L. W., Metcalf J. S. Histological assessment of fifty breast capsules from smooth and textured augmentation and reconstruction mammoplasty prostheses with emphasis on the role of synovial metaplasia. Mod Pathol. 1994 Apr;7(3):310–316. [PubMed] [Google Scholar]
  29. Rudolph R., Abraham J., Vecchione T., Guber S., Woodward M. Myofibroblasts and free silicon around breast implants. Plast Reconstr Surg. 1978 Aug;62(2):185–196. doi: 10.1097/00006534-197808000-00006. [DOI] [PubMed] [Google Scholar]
  30. Sahn E. E., Garen P. D., Silver R. M., Maize J. C. Scleroderma following augmentation mammoplasty. Report of a case and review of the literature. Arch Dermatol. 1990 Sep;126(9):1198–1202. doi: 10.1001/archderm.126.9.1198. [DOI] [PubMed] [Google Scholar]
  31. Silver R. M., Sahn E. E., Allen J. A., Sahn S., Greene W., Maize J. C., Garen P. D. Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol. 1993 Jan;129(1):63–68. [PubMed] [Google Scholar]
  32. Spiera H. Scleroderma after silicone augmentation mammoplasty. JAMA. 1988 Jul 8;260(2):236–238. [PubMed] [Google Scholar]
  33. Sánchez-Guerrero J., Colditz G. A., Karlson E. W., Hunter D. J., Speizer F. E., Liang M. H. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995 Jun 22;332(25):1666–1670. doi: 10.1056/NEJM199506223322502. [DOI] [PubMed] [Google Scholar]
  34. Sánchez-Guerrero J., Schur P. H., Sergent J. S., Liang M. H. Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthritis Rheum. 1994 Feb;37(2):158–168. doi: 10.1002/art.1780370203. [DOI] [PubMed] [Google Scholar]
  35. Thomsen J. L., Christensen L., Nielsen M., Brandt B., Breiting V. B., Felby S., Nielsen E. Histologic changes and silicone concentrations in human breast tissue surrounding silicone breast prostheses. Plast Reconstr Surg. 1990 Jan;85(1):38–41. doi: 10.1097/00006534-199001000-00007. [DOI] [PubMed] [Google Scholar]
  36. Uretsky B. F., O'Brien J. J., Courtiss E. H., Becker M. D. Augmentation mammaplasty associated with a severe systemic illness. Ann Plast Surg. 1979 Nov;3(5):445–447. doi: 10.1097/00000637-197911000-00010. [DOI] [PubMed] [Google Scholar]
  37. Varga J., Jimenez S. A. Augmentation mammoplasty and scleroderma. Is there an association? Arch Dermatol. 1990 Sep;126(9):1220–1222. [PubMed] [Google Scholar]
  38. Varga J., Schumacher H. R., Jimenez S. A. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med. 1989 Sep 1;111(5):377–383. doi: 10.7326/0003-4819-111-5-377. [DOI] [PubMed] [Google Scholar]
  39. Vojdani A., Brautbar N., Campbell A. Immunologic and biologic markers for silicone. Toxicol Ind Health. 1994 Jan-Apr;10(1-2):25–42. doi: 10.1177/074823379401000102. [DOI] [PubMed] [Google Scholar]
  40. Weiner S. R., Paulus H. E. Chronic arthropathy occurring after augmentation mammaplasty. Plast Reconstr Surg. 1986 Feb;77(2):185–192. doi: 10.1097/00006534-198602000-00001. [DOI] [PubMed] [Google Scholar]
  41. Weisman M. H., Vecchione T. R., Albert D., Moore L. T., Mueller M. R. Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg. 1988 Oct;82(4):626–630. doi: 10.1097/00006534-198810000-00011. [DOI] [PubMed] [Google Scholar]
  42. van Nunen S. A., Gatenby P. A., Basten A. Post-mammoplasty connective tissue disease. Arthritis Rheum. 1982 Jun;25(6):694–697. doi: 10.1002/art.1780250613. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES